Eag and HERG potassium channels as novel therapeutic targets in cancer
2010

Eag and HERG Potassium Channels in Cancer

publication Evidence: moderate

Author Information

Author(s): Asher Viren, Sowter Heidi, Shaw Robert, Bali Anish, Khan Raheela

Primary Institution: Royal Derby Hospital, University of Derby

Hypothesis

The review explores the role of Eag and HERG potassium channels as potential therapeutic targets in cancer.

Conclusion

Eag and HERG channels are present in various cancers and may serve as novel therapeutic targets.

Supporting Evidence

  • Eag and HERG channels are expressed in various cancer cell lines.
  • Inhibition of Eag channels has been shown to reduce cancer cell proliferation.
  • Higher expression of Eag correlates with poor prognosis in colorectal cancer.
  • HERG channels are associated with aggressive tumor behavior.
  • Blocking Eag and HERG channels may inhibit cancer progression.

Takeaway

This study looks at two special channels in our cells that can help cancer grow, and it suggests that blocking them might help treat cancer.

Methodology

The review summarizes existing literature on the expression and role of Eag and HERG channels in cancer.

Limitations

The review does not provide new experimental data but relies on existing studies.

Digital Object Identifier (DOI)

10.1186/1477-7819-8-113

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication